Global Medical Device & Data Management Solutions Provider Selects BIO-key for Biometric Systems to Secure Sign-In and e-Signatures

Leveraging Biometric Advantages for Increased Security & Operational Efficiency

WALL, NJ / ACCESSWIRE / May 31, 2017 / BIO-key International, Inc. (OTCQB: BKYI), an innovative provider of biometric software and hardware solutions for strong and convenient user authentication, today reported it has been selected by a global medical device and data management solutions provider, to increase the authentication security and operational efficiency of system sign-in and digital e-signatures throughout their manufacturing process. The company has over 25,000 employees and serves customers in more than 100 countries.

BIO-key’s ID Director for Windows integrates biometric sign-in so users can quickly and securely access desktops and manufacturing systems on any authorized PC across the network. By adding biometrics to enterprise authentication, organizations can reduce the threat of shared or stolen passwords, while significantly reducing the number of spontaneous password resets which average 33% of all help desk calls. Reducing the frequency of organization-wide password resets enhances workplace productivity, and reduces administration expense while reducing unnecessary interruptions in business processes.

The customer also recognized that BIO-key’s biometric “single-sign-on” functionality could be used to substantially increase the speed and security of e-signature approvals within their manufacturing process. On average, a single manufacturing unit may require over 30 e-signatures throughout assembly and quality assurance. Reducing the e-signature workflow down to just a few seconds allows operators and supervisors to save hours of production time over the course of a year, while also delivering enhanced authentication traceability and accountability throughout the manufacturing quality control process.

BIO-key’s line of compact fingerprint readers as well as interoperable support for third-party fingerprint devices ensures that the customer will be able to leverage ID Director for Windows across a wide variety of current and future use-cases requiring strong authentication.

“With the vast majority of businesses operating on Windows 7, 8.1 or 10, BIO-key has invested significant resources to ensure that our biometric authentication solutions integrate seamlessly with these platforms,” stated Barbara Rivera, Chief Operating Officer. “What makes this use case special, but not unique, is that the customer quickly recognized the opportunity for expanded utilization of biometrics within their organization. Additionally, our interoperable capabilities and commitment to support provided the trust and assurance that BIO-key would future proof their biometric security platform and protect their technology investment.”

“Ironically many customers contact BIO-key to address a specific security challenge due to a compelling event. Increasingly, after deploying our technology to address a specific need, we are able to work with customers to identify other compelling use cases. A traditional deployment that might just involve device sign-in, can escalate to the customer wanting to add a layer of biometric sign-in to Active Directory or to use BIO-key software and hardware to sign into their enterprise applications,” added Rivera.

About BIO-key International, Inc. (www.bio-key.com)

BIO-key is revolutionizing authentication with our biometric solutions enabling convenient and secure access to information and securing high-stakes transactions. We offer alternatives to passwords, PINs tokens and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices, including SideSwipe, SideTouch, EcoID and SidePass offer market-leading quality, performance and price. Now anyone can BIO-key their world!

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets, and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.

Investor & Media Contacts

David Collins, William Jones, Tanya Kamatu
Catalyst Global
212-924-9800
bkyi@catalyst-ir.com
Twitter: BIO-keyIR

SOURCE: BIO-key International, Inc.

ReleaseID: 464503